A new study from MIT and Massachusetts Eye and Ear provides evidence that the virus can indeed infect cells of the inner ear, including hair cells, which are critical for both hearing and balance.
In a new column published November 19, 2020 in “The New England Journal of Medicine,” the experts write that the FDA has remained silent after missing the statutory deadline to implement the Over-the-Counter Hearing Aid Act of 2017.
The Sing Registry is a new, observational research study focused on understanding the lifelong impact of genetic sensorineural hearing loss (SNHL), according to the company.
Supporters, patients, and partners of the Callier Center for Communication Disorders came together to share stories, honor award recipients, and raise funds during the sixth annual Callier Cares Luncheon.
Read More
This gift reportedly represents one of the country’s largest philanthropic investments ever to advance research on hearing and hearing loss, a significant public health problem impacting one-third of the world’s population over age 65.
Read More
Two new papers published in Nature Biotechnology on February 6 detail research by scientists at Boston Children’s Hospital—a pediatric teaching hospital affiliated with Harvard Medical School—on an improved gene therapy that helps restore hearing to genetically deaf mice.
Read More
Massachusetts Eye and Ear and Harvard researchers have described, for the first time, the adult brain’s ability to compensate for a near-complete loss of auditory nerve fibers that link the ear to the brain…an imperfect hearing recovery process that may explain why some patients report difficulties understanding speech despite having normal hearing thresholds.
Read More
Several pharmaceutical companies are developing drugs that have potential to treat hearing loss, but they often encounter difficulty demonstrating preclinical efficacy due to challenges regarding concentration of the medication at the intended delivery site. Now researchers have developed a device that can deliver drugs directly to the cochlea—an area of the inner ear difficult to reach with injections and systemic drug delivery.
Read More
Toxic secretions from even apparently benign intracranial tumors can damage the inner ear, according to researchers at Massachusetts Eye and Ear, where they have discovered a new mechanism of vestibular schwannoma, also called acoustic neuroma, that causes hearing loss.
Read More
Massachusetts Eye and Ear researchers have shown that sound deprivation in adult mice causes irreversible damage to the inner ear. The findings, as outlined in the November 18, 2015 edition of PLoS One, suggest that chronic conductive hearing loss, such as that caused by recurrent ear infections, leads to permanent hearing impairment if it remains untreated.
Read More
Scientists have found that salicylates in certain NSAIDs may halt the growth of vestibular schwannomas, also known as acoustic neuromas.
Read More
A research report from Massachusetts Eye and Ear Institute (MEEI) and Harvard Medical School, outlines the ear and hearing problems suffered by surviving victims of the bomb explosions at the April 15, 2013 Boston Marathon. The research report describes the types of otologic injuries people sustained in the tragedy, and the outcomes of the patients undergoing continued otologic treatment.
Read More